The randomised, double-blind, placebo-controlled trial, conducted at Taipei Medical University Hospital, enrolled women diagnosed with fibroids and supplemented them with Oligo Fucoidan for six months.
Key outcomes:
- Fibroid Burden: Participants taking Oligo Fucoidan showed a reduction in fibroid number compared to placebo.
- Quality of Life: WHOQOL-BREF assessments revealed significant improvements in overall quality of life and psychological well-being.
- Safety Profile: No serious adverse events were reported; metabolic, hematologic, and organ function markers remained stable.
The findings highlight marine Oligo Fucoidan’s potential as a safe nutritional approach that complements women’s health management. Hi-Q emphasises that Oligo Fucoidan is not a substitute for medical treatment, but may serve as a natural, functional food option that supports overall well-being.
Expanding Opportunities in Women’s Health Nutrition
Uterine fibroids affect the majority of women during their reproductive years, often impacting daily comfort and quality of life. New research provides preliminary human evidence that marine-derived Oligo Fucoidan supports women’s health through a non-hormonal nutritional approach. As a clinically studied and science-backed ingredient, Oligo Fucoidan offers brand owners fresh opportunities to develop innovative dietary supplements and wellness products tailored to women’s needs.
Full article: Chiang, Y.-F.; Huang, K.-C.; Huang, P.-S.; Ali, M.; Hsia, S.-M. Marine Oligo-Fucoidan as a Safe Functional Food for Managing Uterine Fibroids: Results from a Pilot Randomized Controlled Trial. Biomedicines 2025, 13, 1970.
